As shown in Figure 1A, the analysis revealed that LIPT1 expression was significantly lower in various tumors than in the adjacent normal tissues, including breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), thyroid carcinoma (THCA), uterine corpus endometrial carcinoma (UCEC), kidney chromophobe (KICH). Here, LIPT1 is linked to thyroid gland carcinoma.